CMS Q2 2026 HCPCS Update: 15 New Drug Codes for Oct. 1
CMS’s Q2 2026 HCPCS decisions add 15 new drug and biosimilar codes for October 1 and deny two closely watched revision requests.
·
CMS’s Q2 2026 HCPCS decisions add 15 new drug and biosimilar codes for October 1 and deny two closely watched revision requests.
·
Oncology’s chemo-injection-hydration hierarchy trips up coders and drains revenue. Here’s how agentic AI oncology coding validates sequencing before claims go out.
·